Search alternatives:
advances » advanced (Expand Search)
Showing 1 - 20 results of 37 for search '"Therapeutic Advances in Hematology"', query time: 0.07s Refine Results
  1. 1
    Epstein–Barr virus reactivation after haplo-peripheral blood stem cell transplantation in patients with hematological malignancies: immune reconstitution and influence on survival

    Epstein–Barr virus reactivation after haplo-peripheral blood stem cell transplantation in patients with hematological malignancies: immune reconstitution and influence on survival... by Ling Ma, Ying Zhang, Ting Wang, Yu Cai, Jun Yang, Yin Tong, Chongmei Huang, Huiying Qiu, Kun Zhou, Xiaowei Xu, Jiahua Niu, Chang Shen, Xinxin Xia, Yu Wei, Jie Shao, Min Yang, Jingjing Cao, Xianmin Song, Liping Wan

    Published 2025-05-01
    “…Therapeutic Advances in Hematology…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    BEST study: one-year descriptive follow-up of bevacizumab treatment in hereditary haemorrhagic telangiectasia post-BABH interventional study

    BEST study: one-year descriptive follow-up of bevacizumab treatment in hereditary haemorrhagic telangiectasia post-BABH interventional study by Sophie Dupuis-Girod, Evelyne Decullier, Sophie Rivière, Christian Lavigne, Vincent Grobost, Vanessa Leguy-Seguin, Hélène Maillard, Thierry Chinet, Anne-Emmanuelle Fargeton, Alexandre Guilhem, Ruben Hermann

    Published 2025-04-01
    “…Therapeutic Advances in Hematology…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Experience in the management of patients with HTLV-1 positive adult T-cell leukemia/lymphoma in a Latin American center

    Experience in the management of patients with HTLV-1 positive adult T-cell leukemia/lymphoma in a Latin American center by Danielle Floyd-Aristizábal, Cristian Alonso Barreiro García, Oriana Arias-Valderrama, Catalina Proaño Millán, Nhora María Silva Perez, Joaquín Donaldo Rosales Martinez, Elizabeth Arrieta López

    Published 2025-02-01
    “…Therapeutic Advances in Hematology…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    High expression of malic enzyme 1 predicts adverse prognosis in patients with cytogenetically normal acute myeloid leukaemia and promotes leukaemogenesis through the IL-6/JAK2/STAT3 pathways

    High expression of malic enzyme 1 predicts adverse prognosis in patients with cytogenetically normal acute myeloid leukaemia and promotes leukaemogenesis through the IL-6/JAK2/STAT... by Chang Zhang, Wenlu Li, Fei Wu, Zhongwei Lu, Piaorong Zeng, Zeyu Luo, Yixiong Cao, Feng Wen, Junjun Li, Xi Chen, Fujue Wang

    Published 2024-11-01
    “…Therapeutic Advances in Hematology…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Management of mycosis fungoides and Sézary syndrome with mogamulizumab in combination with psoralen plus UVA: two case reports

    Management of mycosis fungoides and Sézary syndrome with mogamulizumab in combination with psoralen plus UVA: two case reports by Andrea Bernardelli, Carlo Visco

    Published 2025-02-01
    “…Therapeutic Advances in Hematology…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Chronic myeloid leukemia in a patient with beta thalassemia major: a rare presentation

    Chronic myeloid leukemia in a patient with beta thalassemia major: a rare presentation by Alyna Hafeez, Muhammad Usman Shaikh, Abdul Hadi Mallick, Nouman Nathani, Junaid Alam

    Published 2025-07-01
    “…Therapeutic Advances in Hematology…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Thanks to Reviewers

    Thanks to Reviewers

    Published 2025-02-01
    “…Therapeutic Advances in Hematology…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Using T-lymphocyte subsets at engraftment to predict the risk of acute graft-versus-host disease in patients with thalassemia major: development of a new predictive nomogram

    Using T-lymphocyte subsets at engraftment to predict the risk of acute graft-versus-host disease in patients with thalassemia major: development of a new predictive nomogram by Hongwen Xiao, Gaohui Yang, Qiulin Huang, Zhenbin Wei, Zhaoping Gan, Meiqing Wu, Zeyan Shi, Huicheng Huang, Zhaofang Pan, Lianjin Liu, Lingling Shi, Zhongming Zhang, Rongrong Liu, Yongrong Lai

    Published 2024-12-01
    “…Therapeutic Advances in Hematology…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Real-world usage and effectiveness of recombinant factor IX Fc in haemophilia B from the B-SURE study in France

    Real-world usage and effectiveness of recombinant factor IX Fc in haemophilia B from the B-SURE study in France by Hervé Chambost, Yohann Repessé, Fabienne Genre-Volot, Dominique Desprez, Sabine Marie Castet, Stéphane Vanderbecken, Meriem Zidi, Corinne Gandossi, Eveline Nüesch, Helena Palmborg, Elena Santagostino

    Published 2025-01-01
    “…Therapeutic Advances in Hematology…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Successful rechallenge with Erwinia chrysanthemi asparaginase after pegaspargase-induced hypertriglyceridemia: a case report

    Successful rechallenge with Erwinia chrysanthemi asparaginase after pegaspargase-induced hypertriglyceridemia: a case report by Gaia Ciolli, Andrea Pasquini, Francesco Mannelli, Barbara Scappini, Giacomo Gianfaldoni, Elisa Quinti, Laura Fasano, Jessica Caroprese, Francesca Crupi, Alessandro Maria Vannucchi, Matteo Piccini

    Published 2024-09-01
    “…Therapeutic Advances in Hematology…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    The efficacy and safety of asciminib treatment in patients with chronic myeloid leukemia as a second-line or beyond second-line treatment: a systematic review and meta-analysis

    The efficacy and safety of asciminib treatment in patients with chronic myeloid leukemia as a second-line or beyond second-line treatment: a systematic review and meta-analysis by Zixin Fan, Jiayi Xie, Pinying Su, Jingye Tai, Weiyi Feng, Rui Xu, Yun Ouyang

    Published 2025-06-01
    “…Therapeutic Advances in Hematology…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Management of common autoimmune diseases in patients with myeloproliferative neoplasms treated with pegylated interferon alfa—case report, review of the literature and multidisciplinary clinical practice recommendations

    Management of common autoimmune diseases in patients with myeloproliferative neoplasms treated with pegylated interferon alfa—case report, review of the literature and multidiscipl... by Axel Rüfer, Christoph Brand, Andrea de Gottardi, Stefan Fischli, Ralph Melzer, Urs Odermatt, Walter A. Wuillemin, Sacha S. Zeerleder

    Published 2025-05-01
    “…Therapeutic Advances in Hematology…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Outcomes and management of invasive procedures in participants with hemophilia A post gene therapy: a post hoc analysis of the GENEr8-1 phase III trial

    Outcomes and management of invasive procedures in participants with hemophilia A post gene therapy: a post hoc analysis of the GENEr8-1 phase III trial by Doris V. Quon, Jiaan-Der Wang, Michael Wang, Dominic Pepperell, Young-Shil Park, Gili Kenet, Johnny Mahlangu, Teh-Liane Khoo, Tara M. Robinson, Konstantia-Maria Chavele, Steven W. Pipe

    Published 2024-12-01
    “…Therapeutic Advances in Hematology…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Low-dose anti-thymocyte globulin combined with low-dose post-transplant cyclophosphamide: a novel approach to prevent graft-versus-host disease in haploidentical stem cell transplantation

    Low-dose anti-thymocyte globulin combined with low-dose post-transplant cyclophosphamide: a novel approach to prevent graft-versus-host disease in haploidentical stem cell transpla... by Neslihan Mandaci Ṣanli, Ali Ünal

    Published 2025-07-01
    “…Therapeutic Advances in Hematology…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    Calculated haemorheological profile and laboratory parameters in new diagnosed multiple myeloma patients: retrospective analysis according to survival

    Calculated haemorheological profile and laboratory parameters in new diagnosed multiple myeloma patients: retrospective analysis according to survival by Melania Carlisi, Rosalia Lo Presti, Corinne Spoto, Salvatrice Mancuso, Sergio Siragusa, Gregorio Caimi

    Published 2024-11-01
    “…Therapeutic Advances in Hematology…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Predicting cytomegalovirus infection and graft-versus-host disease using QuantiFERON-CMV and Monitor in pediatric transplants: a proof-of-concept study

    Predicting cytomegalovirus infection and graft-versus-host disease using QuantiFERON-CMV and Monitor in pediatric transplants: a proof-of-concept study by Lina Souan, Rawad Rihani, Maher A. Sughayer

    Published 2025-02-01
    “…Therapeutic Advances in Hematology…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    Efficacy of therapeutic strategies on thrombocytopenia after hematopoietic stem cell transplantation—an evidence-based meta-analysis

    Efficacy of therapeutic strategies on thrombocytopenia after hematopoietic stem cell transplantation—an evidence-based meta-analysis by Wenxi Hua, Yunyi Chen, Jiaqian Qi, Xiaofei Song, Meng Zhou, Yue Han

    Published 2025-07-01
    “…Therapeutic Advances in Hematology…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    Association of CVAI, LAP and SMI with risk of haematological toxicity after immunochemotherapy in patients with DLBCL: a retrospective study

    Association of CVAI, LAP and SMI with risk of haematological toxicity after immunochemotherapy in patients with DLBCL: a retrospective study by Caifeng Liao, Hurong Lai, Yansong Tu, Ling He, Chuyang Lin, Huaijun Tu, Jian Li

    Published 2025-01-01
    “…Therapeutic Advances in Hematology…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    Hypomethylating agent versus venetoclax combination: an electronic health records-based target trial emulation among Asian elderly patients with newly diagnosed acute myeloid leukaemia in Hong Kong

    Hypomethylating agent versus venetoclax combination: an electronic health records-based target trial emulation among Asian elderly patients with newly diagnosed acute myeloid leuka... by Qiwen Fang, Chi Yeung Fung, Jiaqi Wang, Wing Hei Lai, Raymond S. M. Wong, Bonnie C. S. Kho, June S. M. Lau, Vivien W. M. Mak, Chung Yin Ha, Xue Li, Anskar Yu-Hung Leung

    Published 2025-07-01
    “…Therapeutic Advances in Hematology…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    Integrated Immune Landscape Analysis of RNA Splicing Factor-Mutant AML and Higher risk MDS Treated with Azacitidine ± Durvalumab

    Integrated Immune Landscape Analysis of RNA Splicing Factor-Mutant AML and Higher risk MDS Treated with Azacitidine ± Durvalumab by Jan Philipp Bewersdorf, Vanessa Hasle, Rory M. Shallis, Ethan Thompson, Daniel Lopes de Menezes, Shelonitda Rose, Isaac Boss, Lourdes Mendez, Nikolai Podoltsev, Maximilian Stahl, Tariq Kewan, Stephanie Halene, Torsten Haferlach, Brian A. Fox, Amer M. Zeidan

    Published 2025-06-01
    “…Therapeutic Advances in Hematology…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: